Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
San Diego, CA
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Denver, CO
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Atlanta, GA
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Evanston, IL
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Kansas City, KA
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Baltimore, MD
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
St Louis, MO
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Kalispell, MT
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Kalispell, MT
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Grand Island, NE
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Grand Island, NE
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Teaneck, NJ
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Bronx, NY
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Akron, OH
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Bend, OR
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Allentown, PA
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Houston, TX
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Annandale, VA
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Annandale, VA
Click here to add this to my saved trials
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated:  12/20/2012
Clinical Research Facility
mi
from
Beloit, WI
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 ug Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma
Status: Enrolling
Updated: 12/20/2012
Clinical Research Facility
mi
from
Beloit, WI
Click here to add this to my saved trials
Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations
A Randomized Controlled Trial of Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations
Status: Enrolling
Updated:  1/1/2013
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations
A Randomized Controlled Trial of Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations
Status: Enrolling
Updated: 1/1/2013
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Research Facility
mi
from
San Diego, CA
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Research Facility
mi
from
Denver, CO
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Research Facility
mi
from
Baltimore, MD
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Research Facility
mi
from
Allentown, PA
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Research Facility
mi
from
Beloit, WI
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Allergic Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Research Facility
mi
from
Beloit, WI
Click here to add this to my saved trials
Immune Dysfunction in Allergic Asthma
Not a Drug Trial. We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma
Status: Enrolling
Updated:  1/18/2013
UNM HSC
mi
from
Albuquerque, NM
Immune Dysfunction in Allergic Asthma
Not a Drug Trial. We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma
Status: Enrolling
Updated: 1/18/2013
UNM HSC
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Little Rock Allergy & Asthma Clinical Research Center
mi
from
Little Rock, AR
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Little Rock Allergy & Asthma Clinical Research Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
West Coast Clinical Trials, LLC
mi
from
Cypress, CA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
West Coast Clinical Trials, LLC
mi
from
Cypress, CA
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Allergy & Asthma Care Center of Southern California
mi
from
Long Beach, CA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Allergy & Asthma Care Center of Southern California
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Clinical Trials of Orange County, Inc.
mi
from
Orange, CA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Clinical Trials of Orange County, Inc.
mi
from
Orange, CA
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Allergy and Asthma Consultants
mi
from
Redwood, CA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Allergy and Asthma Consultants
mi
from
Redwood, CA
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
IMMUNOe International Research Centers
mi
from
Southwest Arapahoe, CO
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
IMMUNOe International Research Centers
mi
from
Southwest Arapahoe, CO
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
All Seasons Allergy and Asthma Center, P.A.
mi
from
Fort Walton Beach, FL
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
All Seasons Allergy and Asthma Center, P.A.
mi
from
Fort Walton Beach, FL
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Palm Beach Research Center
mi
from
West Palm Beach, FL
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Brookstone Centre Parkway
mi
from
Columbus, GA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Brookstone Centre Parkway
mi
from
Columbus, GA
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Rush University Medical Center
mi
from
Chicago, IL
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Northern Illinois Research Associates
mi
from
DeKalb, IL
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Northern Illinois Research Associates
mi
from
DeKalb, IL
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Nassim, McMonigle, Mescia & Associates
mi
from
New Albany, IN
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Nassim, McMonigle, Mescia & Associates
mi
from
New Albany, IN
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Grand Blanc Medical
mi
from
Grand Blanc, MI
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Grand Blanc Medical
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Craig A. Spiegel MD
mi
from
Bridgeton, MO
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Craig A. Spiegel MD
mi
from
Bridgeton, MO
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Midwest Allergy and Asthma center
mi
from
Omaha, NE
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Midwest Allergy and Asthma center
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Maimonides Medical Center
mi
from
Brooklyn, NY
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
St. Elizabeth Health Center
mi
from
Utica, NY
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
St. Elizabeth Health Center
mi
from
Utica, NY
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Dayton Clinical Research
mi
from
Dayton, OH
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Dayton Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated:  1/31/2013
Eminence Research, LLC
mi
from
Oklahoma City, OK
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Eminence Research, LLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials